IP Library Granted Patent US 10,167,325
Granted Patent B2
US 10,167,325 · App. 15/186,831 · Granted Jan 1, 2019

Plant-derived elastin binding protein ligands and methods of using the same

Inventors: Felipe Jimenez (Seal Beach, CA); Thomas Mitts (Visalia, CA); Aleksander Hinek (Toronto, CA)
Assignees: Human Matrix Sciences, LLC; The Hospital for Sick Children
C07K14/415A61K8/19A61K8/645A61K9/0014A61K33/26A61K33/32A61K33/34A61K38/168A61Q19/00C07K7/06C07K7/08A61K38/00A61K2800/74
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,167,325
App. No.
15/186,831
Granted
Jan 1, 2019
Kind
B2
Abstract

The present invention describes novel plant derived elastin-like peptides and peptidomimetics that may serve as functional ligands for elastin receptors and stimulate elastogenesis. The novel plant derived peptides provide an alternative (non-animal derived) source of GXXPG (SEQ ID NO. 2) containing peptides. The present invention also describes therapeutic compositions containing novel plant derived peptides or peptidomimetics useful in stimulating elastogenensis and capillary dilatation. The therapeutic compositions of the present invention that comprise novel plant derived peptides or peptidomimetics may be combined with other therapeutic agents.

Claims (12)

1. A synthetic acetylated peptide comprising a sequence of IGVAPG (SEQ ID NO: 13), wherein acetylation is at N-terminus.

2. The synthetic acetylated peptide of claim 1 , wherein the peptide stimulates elastogenesis.

3. A composition comprising an acetylated peptide comprising a sequence of IGVAPG (SEQ ID NO: 13), wherein acetylation is at N-terminus.

4. The composition of claim 3 , wherein the acetylated peptide is in an effective amount.

5. The composition of claim 3 , wherein the composition stimulates elastogenesis.

6. The composition of claim 3 , wherein the composition is a solution, a cream, an emulsion, a gel, a solid, or an aerosol.

7. The composition of claim 3 , further comprising a manganese compound, a trivalent iron compound, a sodium compound, a copper compound, an antioxidant, an additive, an excipient, or combinations thereof.

8. A method of improving the appearance of the skin comprising administering an effective amount of a composition comprising an acetylated peptide comprising a sequence IGVAPG (SEQ ID NO: 13), wherein acetylation is at N-terminus.

9. The method of claim 8 , wherein the composition provides an appearance of increased elastogenesis in a tissue.

10. The method of claim 8 , wherein the composition stimulates proliferation and migration of dermal fibroblasts into an area of skin.

11. The method of claim 8 , wherein the composition increases elastogenesis.

12. The method of claim 8 , wherein the administering includes at least one of topical application and application via a transdermal patch.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2024
From: ELASTOGENESIS LLC
To: NULASTIN, INC.
Reel/Frame 068190/0171 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2024
From: THE HOSPITAL FOR SICK CHILDREN
To: ELASTOGENESIS LLC
Reel/Frame 067829/0336 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2019
From: HUMAN MATRIX SCIENCES, LLC
To: ELASTOGENESIS, LLC
Reel/Frame 048891/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2017
From: MITTS, THOMAS F.; JIMENEZ, FELIPE
To: HUMAN MATRIX SCIENCES, LLC
Reel/Frame 044470/0314 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2017
From: HINEK, ALEKSANDER
To: THE HOSPITAL FOR SICK CHILDREN
Reel/Frame 044470/0343 →
Continuity (6)
Continuation 13975703 · Aug 26, 2013
Continuation 12781710 · May 17, 2010
Continuation 11405843 · Apr 17, 2006
Provisional Application 60671557 · Apr 15, 2005
Provisional Application 60737586 · Nov 17, 2005
Related Publication 20170002047A1 · Jan 5, 2017